Detalhe da pesquisa
1.
Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.
Br J Haematol
; 204(4): 1439-1449, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807708
2.
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis.
Ann Hematol
; 102(6): 1501-1511, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088816
3.
Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients.
Br J Clin Pharmacol
; 89(4): 1452-1461, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36422512
4.
Identification of patients at high risk of secondary extramedullary multiple myeloma development.
Br J Haematol
; 196(4): 954-962, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726261
5.
Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data.
Neoplasma
; 69(6): 1474-1479, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36591805
6.
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice.
BMC Cancer
; 21(1): 73, 2021 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33451293
7.
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data.
Eur J Haematol
; 107(4): 466-474, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272773
8.
Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group model.
Br J Haematol
; 190(2): 189-197, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32163180
9.
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.
Am J Hematol
; 95(5): 503-509, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072687
10.
Improved laboratory diagnostics of Streptococcus pneumoniae in respiratory tract samples through qPCR.
New Microbiol
; 43(2): 70-77, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32310299
11.
Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma.
Br J Haematol
; 187(4): 447-458, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31388996
12.
Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients.
Am J Hematol
; 94(10): 1132-1140, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31334859
13.
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.
Biol Blood Marrow Transplant
; 24(7): 1372-1378, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29408334
14.
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.
Br J Haematol
; 180(6): 831-839, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29315478
15.
Human polyomavirus 9 in immunocompromised patients in the University Hospital in Hradec Kralove, Czech Republic.
J Med Virol
; 89(12): 2230-2234, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28667764
16.
A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance.
Eur J Haematol
; 99(1): 80-90, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28384387
17.
Treatment of Multifocal Multisystem BRAF Positive Langerhans Cell Histiocytosis with Cladribine, Surgery and Allogenic Stem Cell Transplantation.
Acta Medica (Hradec Kralove)
; 60(4): 152-156, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29716681
18.
[Valvular heart disease in relation to the treatment of hyperprolactinemia with dopamine agonists]. / Chlopenní vady pri lécbe hyperprolaktinemie dopaminovými agonisty.
Vnitr Lek
; 63(9): 561-565, 2017.
Artigo
em Cs
| MEDLINE | ID: mdl-29120651
19.
Multicentered patient-based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapse.
Eur J Haematol
; 96(2): 119-27, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25816709
20.
[Impact of age on the clinical response of patients with CML treated with imatinib]. / Má vek nemocných s chronickou myeloidní leukemií pri lécbe imatinibem vliv na dosazenou lécebnou odpoved?
Vnitr Lek
; 61(9): 785-6, 788-91, 2015 Sep.
Artigo
em Cs
| MEDLINE | ID: mdl-26465277